Mutations in PON1 or other ROS modulating genes may result in an altered gut microbiome as an intermediate mechanism for diseases such as atherosclerosis and diabetes mellitus, and may also affect important traits such as longevity. The gene discussed is PON1; the disease is atherosclerosis.